09-11-2007, 03:20 PM
Crohn™s disease is a cell-mediated autoimmune inflammatory disease of the colon. A new therapy uses humanized monoclonal antibodies to a cytokine, which breaks the cycle of inflammation. Antibody to which of the following cytokines would be appropriate therapy?
A. Interleukin-2 (IL-2)
B. Interleukin-4 (IL-4)
C. Interleukin-10 (IL-10)
D. Interleukin-12 (IL-12)
E. Transforming growth factor beta (TGF-beta
A. Interleukin-2 (IL-2)
B. Interleukin-4 (IL-4)
C. Interleukin-10 (IL-10)
D. Interleukin-12 (IL-12)
E. Transforming growth factor beta (TGF-beta